Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pediatric Chordoma: A Tale of Two Genomes.
O'Halloran K, Hakimjavadi H, Bootwalla M, Ostrow D, Kerawala R, Cotter JA, Yellapantula V, Kaneva K, Wadhwani NR, Treece A, Foreman NK, Alexandrescu S, Velazquez Vega J, Biegel JA, Gai X. O'Halloran K, et al. Mol Cancer Res. 2024 May 1. doi: 10.1158/1541-7786.MCR-23-0741. Online ahead of print. Mol Cancer Res. 2024. PMID: 38691518
The spectrum of mitochondrial DNA (mtDNA) mutations in pediatric CNS tumors.
Kaneva K, O'Halloran K, Triska P, Liu X, Merkurjev D, Bootwalla M, Ryutov A, Cotter JA, Ostrow D, Biegel JA, Gai X. Kaneva K, et al. Neurooncol Adv. 2021 Jun 2;3(1):vdab074. doi: 10.1093/noajnl/vdab074. eCollection 2021 Jan-Dec. Neurooncol Adv. 2021. PMID: 34337412 Free PMC article.
Low-pass whole-genome and targeted sequencing of cell-free DNA from cerebrospinal fluid in pediatric patients with central nervous system tumors.
O'Halloran K, Yellapantula V, Christodoulou E, Ostrow D, Bootwalla M, Ji J, Cotter J, Chapman N, Chu J, Margol A, Krieger MD, Chiarelli PA, Gai X, Biegel JA. O'Halloran K, et al. Neurooncol Adv. 2023 Jun 28;5(1):vdad077. doi: 10.1093/noajnl/vdad077. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37461402 Free PMC article.
Effective re-induction regimen for children with recurrent medulloblastoma.
O'Halloran K, Phadnis S, Friedman GK, Metrock K, Davidson TB, Robison NJ, Tamrazi B, Cotter JA, Dhall G, Margol AS. O'Halloran K, et al. Neurooncol Adv. 2024 May 10;6(1):vdae070. doi: 10.1093/noajnl/vdae070. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38863988 Free PMC article.
Personalizing the treatment of pediatric medulloblastoma: Polo-like kinase 1 as a molecular target in high-risk children.
Triscott J, Lee C, Foster C, Manoranjan B, Pambid MR, Berns R, Fotovati A, Venugopal C, O'Halloran K, Narendran A, Hawkins C, Ramaswamy V, Bouffet E, Taylor MD, Singhal A, Hukin J, Rassekh R, Yip S, Northcott P, Singh SK, Dunham C, Dunn SE. Triscott J, et al. Cancer Res. 2013 Nov 15;73(22):6734-44. doi: 10.1158/0008-5472.CAN-12-4331. Epub 2013 Sep 9. Cancer Res. 2013. PMID: 24019381
308 results